Research Articles | Page 6 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
The Importance of Controlling Terminal Complement Activity and Intravascular Hemolysis in Paroxysmal Nocturnal Hemoglobinuria (PNH) Mar 2025 American Journal of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications Nov 2020 Cells Myelodysplastic Syndromes (MDS)
The evolving role of next generation sequencing in myelodysplastic syndromes Oct 2019 British Journal of Haematology Myelodysplastic Syndromes (MDS)
The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia Jan 2021 Seminars in Hematology Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria May 2023 International Journal of Molecular Sciences Paroxysmal Nocturnal Hemoglobinuria (PNH)
The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia Sep 2024 Annals of Hematology Aplastic Anemia
The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes Jan 2019 Blood Myelodysplastic Syndromes (MDS)
The case for upfront HLA-matched unrelated donor HCT as a curative option for adult acquired severe aplastic anemia: Upfront MUD HCT for adult severe aplastic anemia May 2019 Biology of Blood and Marrow Transplantation: Journal of the American Society of Blood and Marrow Transplantation Aplastic Anemia
Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, single-arm clinical trial Nov 2024 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, single-arm clinical trial Apr 2025 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)